Emulate nabs $82M to scale its organ-on-a-chip business

By The Science Advisory Board staff writers

September 7, 2021 -- Emulate has secured $82 million in a series E financing round led by existing investor Northpond Ventures.

Perceptive Advisors also participated in the funding round. Emulate will use the funds to expand R&D and scale its commercial organization to support a global customer base for its organ-on-a-chip technology, according to the company. Emulate has raised a total of $225 million.

Emulate launches new colon-intestine chips
Emulate has launched its Emulate Colon Intestine-Chip, a complete, lab-ready human emulation system to allow researchers to recapitulate specific human...
Emulate says 'lung chips' to be used to study COVID-19
Emulate said that the U.S. Army will be using its Alveolus Lung-Chip technology to study the effects of the SARS-CoV-2 virus on human lung tissue.
Emulate to provide FDA with 'lung chips' to evaluate COVID-19 vaccines
Emulate has entered a cooperative research and development agreement with the U.S. Food and Drug Administration (FDA) to enable multiple studies to evaluate...

Copyright © 2021 scienceboard.net

Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter